Peptimize: GLP-1 Tracker

Peptimize: GLP-1 Tracker

Dose, Weight & Injection Log

0 ratings
Free

Rating summary

Details

  • Released
  • Updated
  • August 9, 2026
  • August 9, 2026

Features

Peptimize: GLP-1 Tracker screenshot #1 for iPhone
Peptimize: GLP-1 Tracker screenshot #2 for iPhone
Peptimize: GLP-1 Tracker screenshot #3 for iPhone
Peptimize: GLP-1 Tracker screenshot #4 for iPhone
Peptimize: GLP-1 Tracker screenshot #5 for iPhone
Peptimize: GLP-1 Tracker screenshot #6 for iPhone
Peptimize: GLP-1 Tracker screenshot #7 for iPhone
Peptimize: GLP-1 Tracker screenshot #8 for iPhone
Peptimize: GLP-1 Tracker screenshot #9 for iPhone
🖼️Get Icon
Icons↘︎

About

Peptimize is a privacy-first companion for keeping your GLP-1 and peptide routine organised in one place. TRACK YOUR ROUTINE • Log doses with the date, time, amount, route, injection site and personal notes. • View your next scheduled dose and keep a clear history of previous entries. • Use local reminders to stay organised. FOLLOW YOUR PROGRESS • Record weight and view changes over time. • Log symptoms and side effects with severity and notes. • Track appetite, food noise, protein intake and hydration. • Keep an eye on medication inventory and remaining doses. ROTATE INJECTION SITES Use the visual body map to record injection sites and make site rotation easier to follow. REFERENCE INFORMATION Browse a medication and peptide research library with links to primary sources. Educational material is clearly separated from your personal tracking records. PRIVATE BY DESIGN Peptimize v1 does not require an account. Your tracking information is stored locally on your device and is not synced to a Peptimize account or cloud service. IMPORTANT Peptimize is a record-keeping and educational tool. It does not diagnose, treat, prescribe, recommend a medication or dose, or replace advice from a qualified healthcare professional. Enter only the medication and schedule provided or approved by your healthcare professional.
Show more

What's New in Peptimize

1.0.0

August 9, 2026